Fig. 2: Fibrin drives lung pathology after SARS-CoV-2 infection. | Nature

Fig. 2: Fibrin drives lung pathology after SARS-CoV-2 infection.

From: Fibrin drives thromboinflammation and neuropathology in COVID-19

Fig. 2

a, Lung pathology of Beta-infected WT, Fga−/− and Fggγ390–396A mice. b, Microscopy analysis of Mac2 (macrophages) and fibrin/fibrinogen in uninfected (UI) (n = 4) and Beta-infected WT (n =10), Fga−/− (n = 10) and Fggγ390–396A (n = 9) mice; gp91phox in uninfected (n = 3) and Beta-infected WT (n = 10), Fga−/− (n = 10) and Fggγ390–396A (n = 9) mice; and Trichrome (collagen, blue; fibrin, red) in uninfected (n = 4) and Beta-infected WT (n = 5), Fga−/− (n = 5), Fggγ390–396A (n = 4) mice. Data are from mice infected in two independent experiments. c, Gene set enrichment analysis (GSEA) of pathways significantly altered in Beta-infected lungs of Fga−/− mice compared with WT mice. NES, normalized enrichment score. d, Significant genes and pathways. Uninfected: n = 4 (WT) and n = 3 (Fga−/−) mice; Beta: n = 4 (WT) and n = 5 (Fga–/–) mice. e, Microscopy analysis of NKp46, granzyme and spike in lung after infection. NKp46: uninfected, n = 8 (WT); infected, n = 10 (WT), n = 10 (Fga−/−) and n = 9 (Fggγ390–396A) mice; granzyme: uninfected, n = 4 (WT); infected, n = 5 mice per group; spike: uninfected, n = 4 (WT); infected: n = 10 (WT), n = 10 (Fga−/−) and n = 9 (Fggγ390–396A) mice. Statistical analysis was performed using one-way ANOVA with Tukey’s multiple-comparison test (b and e) and two-sided quasi-likelihood F-test implemented in edgeR (d). In d, bold font indicates adjusted P < 0.05 (Benjamini–Hochberg). Each lane represents the average scaled z-score for each genotype. Data are mean ± s.e.m. Scale bars, 100 μm (b and e). The diagram in a was created with BioRender.

Source Data

Back to article page